@prefix xsd:<http://www.w3.org/2001/XMLSchema#> .
@prefix civic: <http://purl.jp/bio/10/civic/> .
@prefix civico: <http://purl.jp/bio/10/civic/ontology#> .
@prefix civicg: <https://civic.genome.wustl.edu/links/genes/> .
@prefix civicv: <https://civic.genome.wustl.edu/links/variants/> .
@prefix civice: <https://civic.genome.wustl.edu/links/evidence_items/> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ensembl: <http://identifiers.org/ensembl/> .
@prefix faldo: <http://biohackathon.org/resource/faldo#> .
@prefix hco: <http://identifiers.org/hco/> .
@prefix m2r: <http://med2rdf/org/ontology/med2rdf#> .
@prefix pbm: <http://identifiers.org/pubmed/> .
@prefix sio: <http://semanticscience.org/resource/> .
@prefix dct:<http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .

civicg:28
    rdfs:seeAlso <http://identifiers.org/ncbigene/3717> ;
    dcterms:identifier "28" ;
    m2r:variation civicv:64,civicv:571,civicv:615,civicv:1681 ;
    rdfs:label "JAK2" ;
    a m2r:Gene .

civicv:86
    rdfs:label "EXON 12 MUTATION" ;
    m2r:evidence civice:108,civice:111,civice:116,civice:117,civice:118,civice:119,civice:120,civice:137,civice:146,civice:147,civice:148,civice:149,civice:150,civice:151,civice:173,civice:174,civice:175,civice:176,civice:177,civice:179,civice:180,civice:181,civice:182,civice:183,civice:184,civice:185,civice:196,civice:199,civice:1102,civice:1369 ;
    faldo:location [ 
    a faldo:Region ;
        faldo:begin [
            a faldo:ExactPosition ;
            faldo:position 170837531 ;
            faldo:reference hco:5\#GRCh37
        ];
	    faldo:end [
            a faldo:ExactPosition ;
            faldo:position 170837569 ;
            faldo:reference hco:5\#GRCh37
        ]
    ] ;
    civico:referenceBuild "GRCh37" ;
    civico:transcript "ENST00000517671.1" ;
    civico:ensemblVersion "75" ;
    civico:variantOrigin "Somatic Mutation" ;
    dcterms:description "NPM1 exon 12 mutations are frequently identified in patients with cytogenetically normal acute myeloid leukemia (AML) and often co-occur with FLT3-ITD. FLT3 status should also be evaluated as co-occurence with FLT3-ITD may impact prognosis. Exon 12 mutations have been identified as a predictor of good prognostic outcomes in the absence of FLT3-ITD. Due to their high frequency, NPM1 mutations have been retrospectively analyzed in the context of a number of therapies including variable results following ATRA treatment as well as improved response to high-dose daunorubicin or valproic acid. Additionally, multiple groups have shown increased surface expression of CD33 associated with NPM1 mutation, suggesting these patients may respond to anti-CD33 therapy. Cytoplasmic sequestration of NPM1 (NPM1c) is associated with a good response to induction therapy." ;
    m2r:disease civic:AcuteMyeloidLeukemia ;
    dcterms:identifier "86" ;
    civico:variantGroups "NPM1 Exon 12" ;
    a obo:exon_variant, m2r:Variation .


civicv:1972
    rdfs:label "Splicing alteration (c.463+1G>A)" ;
    civico:hgvs "NM_000551.3:c.463+1G>A,NC_000003.11:g.10188321G>A,ENST00000256474.2:c.463+1G>A" ;
    dcterms:identifier "1972" ;
    a m2r:Variation .

civice:1
    dct:references pbm:16081687 ;
    civico:citation "Levine et al., 2005, Blood" ;
    civico:rating "4.0" ;
    civico:evidenceStatus "accepted" ;
    civico:evidenceType "Diagnostic" ;
    civico:evidenceDirection "Supports" ;
    civico:clinicalSignificance "Negative" ;
    civico:evidenceLevel "B" ;
    dcterms:description "JAK2 V617F is not associated with lymphoid leukemia (B-lineage ALL, T-ALL or CLL)." ;
    a m2r:Evidence .

civic:LymphoidLeukemia
    rdfs:seeAlso obo:DOID_10747 ;
    rdfs:label "Lymphoid Leukemia" ;
    a m2r:Disease .

civic:drug_Daunorubicin
    rdfs:label "Daunorubicin" ;
    a m2r:Drug .

